Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jul 28, 2015
Quick Take: Gilead Blows By 2Q Estimates; Investors Getting Drug Pipeline for Free
We continue to like the company that found a way to cure hepatitis C. Jul 28, 2015
The Chinese Market Is Rigged
Let’s face it. Nobody knows where the market clearing price is for most of the companies listed on the Chinese exchanges. The government won’t allow price discovery, which means “real” prices are far lower than today’s levels. Jul 26, 2015
Dividend Increases for the Week Ending July 24
Let's take a look at companies raising their dividends this week. Jul 26, 2015
Selecting Winners
Visa continues to be a key position in the Best Ideas Newsletter portfolio as it outpaces even the strength of its peers. Jul 24, 2015
Organic Growth Sweetens Nonalcoholic Beverage Industry
Major players in the nonalcoholic beverage industry reported solid currency neutral results in the second quarter. Let’s take a look. Jul 23, 2015
Guide to Second Quarter Earnings; Big Pharma Experiencing Earnings Momentum
Abbott, Bristol-Myers, Celgene, Eli Lilly, Novartis, Roche, Valeant… Jul 22, 2015
Guide to Second Quarter Earnings; Big Cap Tech Sets Somber Mood
Apple, IBM, Lexmark, Linear, Microsoft, Verizon, Yahoo… Jul 22, 2015
Aerospace and Automotive Demand Powering Most Industrials
We highlight winners and losers in commercial aerospace, our two primary concerns in the auto sector, and the dichotomy within the industrial energy vertical. Jul 20, 2015
Intel Beats Consensus Estimates and Weak PC Demand
Newsletter portfolio holding Intel reported solid results in the second quarter of 2015. Let’s take a closer look. Jul 16, 2015
Kinder Morgan Continues Down Unsustainable Path
"The second quarter showed that fundamental performance is weakening, leverage is increasing, and that energy price uncertainty has heightened--yet Kinder Morgan’s management team continues to raise the dividend, a 14% year-over-year increase in the last period. Something is coming to a head, and we don’t think it will end well for equity holders. We expect an additional 20% downside from here." -- Valuentum
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
